FDA Grants Approval to Atezolizumab for Alveolar Soft Part Sarcoma

On December 9, 2022, the Food and Drug Administration (FDA) approved atezolizumab (Tecentriq, Genentech, Inc.) for […]
Dear ASPS community, please read the recent update of this clinical trial from September 2020: This […]
The American Society of Clinical Oncology (ASCO) annual meeting took place this year in Chicago between […]
Below are summaries of three clinical studies and one preclinical study on Alveolar Soft Part Sarcoma […]
OPEN NOW: ​​​APROMISS – A Phase III Study of AL3818 (Anlotinib) Hydrochloride Monotherapy in Subjects With […]
A presentation is the recent annual meeting of the American Society of Clinical Oncology (ASCO) conference […]
The summary of the phase 2 clinical trial of Cediranib on Alveolar Soft Part Sarcoma was […]
If you consider to join the following clinical trial: Sunitinib or Cediranib for Alveolar Soft Part […]